蛋白質工程市場－全球產業規模、佔有率、趨勢、機會和預測（按產品類型、技術、最終用戶、地區和競爭細分，2020-2030 年）

2024 年全球蛋白質工程市場價值為 28.7 億美元，預計到 2030 年將達到 57.4 億美元，預測期內複合年成長率為 12.25%。蛋白質工程是生物技術的一個專業分支，專注於設計、修改和最佳化蛋白質以增強或創造新的功能。這些蛋白質在生物系統中的催化、訊號傳導、分子運輸和結構完整性中發揮著至關重要的作用。分子生物學技術的進步現在使研究人員能夠合成和改變編碼特定蛋白質的基因，從而促進新型和改良生物分子的開發。隨著從治療性抗體到農業創新等應用領域對工程蛋白質的需求不斷成長，市場持續快速擴張。政府支持的研究資金、不斷成長的私人投資以及人工智慧藥物設計等創新驅動的舉措正在加速市場發展。例如，Nabla Bio 在 2021 年籌集了 1,100 萬美元，用於建立下一代抗體療法的 AI 優先平台，體現了該領域的發展勢頭。

關鍵市場促進因素

技術進步

主要市場挑戰

蛋白質設計的複雜性

主要市場趨勢

蛋白質工程在農業的擴展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球蛋白質工程市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品類型（胰島素、單株抗體、凝血因子（血液因子+組織纖溶酶原）、疫苗、生長因子（荷爾蒙+細胞激素）和其他產品類型）
  • 按技術（非合理蛋白質設計和合理蛋白質設計）
  • 按最終用戶（製藥和生物技術公司、學術機構和合約研究組織 (CRO)）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：亞太蛋白質工程市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第7章：歐洲蛋白質工程市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 西班牙
  • 義大利
  • 英國

第8章：北美蛋白質工程市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第9章：南美洲蛋白質工程市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲蛋白質工程市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第 13 章：全球蛋白質工程市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章： 大環境分析

第 16 章：競爭格局

• Agilent Technologies Inc.
• Amgen Inc.
• Bruker Corporation
• Bio-Rad Laboratories Inc.
• Eli Lilly and Company
• Merck KGaA
• Novo Nordisk AS
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Waters Corporation

第 17 章：策略建議

第18章調查會社について,免責事項

The Global Protein Engineering Market was valued at USD 2.87 billion in 2024 and is projected to reach USD 5.74 billion by 2030, growing at a CAGR of 12.25% during the forecast period. Protein engineering is a specialized branch of biotechnology that focuses on designing, modifying, and optimizing proteins to enhance or create new functionalities. These proteins serve vital roles in catalysis, signaling, molecular transport, and structural integrity within living systems. Technological advancements in molecular biology now allow researchers to synthesize and alter genes encoding specific proteins, facilitating the development of novel and improved biological molecules. As the demand grows for engineered proteins in applications ranging from therapeutic antibodies to agricultural innovations, the market continues to expand rapidly. Government-backed research funding, growing private investments, and innovation-driven initiatives-such as AI-enabled drug design-are accelerating market development. For instance, Nabla Bio raised USD 11 million in 2021 to build an AI-first platform for next-generation antibody therapeutics, exemplifying the momentum in this sector.

Key Market Drivers

Technological Advancements

Cutting-edge technologies have been instrumental in driving the evolution and expansion of protein engineering applications across sectors such as healthcare, agriculture, and industrial biotechnology. CRISPR-Cas9 has revolutionized gene editing by enabling precise, efficient protein modifications. Directed evolution techniques allow researchers to mimic natural selection in the laboratory to optimize protein functions through iterative mutation and screening. High-throughput screening (HTS) systems have improved the speed and scale of protein testing, enabling rapid identification of proteins with desirable traits. Computational tools, including AI and molecular modeling, now support accurate protein structure predictions and help streamline the design process. Synthetic biology allows for de novo construction of proteins with tailored functionalities, while advances in protein expression systems (yeast, bacterial, and mammalian) have enhanced recombinant protein yields and quality. Collectively, these innovations are facilitating the development of therapeutic proteins, industrial enzymes, and bioengineered agricultural products with unprecedented efficiency.

Key Market Challenges

Complexity of Protein Design

One of the primary challenges in protein engineering is the inherent complexity of protein design. Proteins rely on intricate three-dimensional folding to function correctly, and even minor alterations in amino acid sequences can result in misfolding and loss of activity. Designing proteins that not only fold properly but also exhibit desired properties-such as stability, specificity, and bioactivity-is a highly complex task. Predicting functional outcomes, ensuring correct protein-ligand or protein-protein interactions, and maintaining stability under physiological conditions remain difficult. Additionally, successful protein design demands multidisciplinary expertise in structural biology, computational modeling, bioinformatics, and chemistry, making collaboration essential. These scientific and technical hurdles limit the pace of development and adoption in certain application areas, especially where precision and reproducibility are critical.

Key Market Trends

Expansion of Protein Engineering in Agriculture

Protein engineering is witnessing a growing footprint in agricultural biotechnology. By modifying plant proteins and enzymes, researchers are enhancing crop traits such as pest resistance, disease tolerance, and resilience to environmental stressors like drought and salinity. Engineered crops can also be enriched with essential nutrients, addressing malnutrition through biofortification. These advances reduce the need for chemical inputs like pesticides and fertilizers, promoting more sustainable and eco-friendly farming practices. Protein engineering enables the development of genetically modified organisms (GMOs) with targeted improvements, supporting food security and environmental sustainability. The trend toward nutrient-dense and climate-resilient crops underscores the increasing role of protein engineering in transforming agriculture globally.

Key Market Players

• Agilent Technologies Inc.
• Amgen Inc.
• Bruker Corporation
• Bio-Rad Laboratories Inc.
• Eli Lilly and Company
• Merck KGaA
• Novo Nordisk AS
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Waters Corporation

Report Scope:

In this report, the Global Protein Engineering Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Engineering Market, By Product Type:

• Insulin
• Monoclonal Antibodies
• Coagulation Factors (Blood Factors + Tissue Plasminogen)
• Vaccines
• Growth Factors (Hormones + Cytokine)
• Other Product Types

Protein Engineering Market, By Technology:

• Irrational Protein Design
• Rational Protein Design

Protein Engineering Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Academic Institutions
• Contract Research Organizations (CROs)

Protein Engineering Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Engineering Market.

Available Customizations:

Global Protein Engineering Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Engineering Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Insulin, Monoclonal Antibodies, Coagulation Factors (Blood Factors + Tissue Plasminogen), Vaccines, Growth Factors (Hormones + Cytokine), and Other Product Types)
  • 5.2.2. By Technology (Irrational Protein Design and Rational Protein Design)
  • 5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations (CROs))
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Protein Engineering Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Protein Engineering Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End User
  • 6.3.2. India Protein Engineering Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End User
  • 6.3.3. Australia Protein Engineering Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End User
  • 6.3.4. Japan Protein Engineering Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By Technology
      • 6.3.4.2.3. By End User
  • 6.3.5. South Korea Protein Engineering Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By Technology
      • 6.3.5.2.3. By End User

7. Europe Protein Engineering Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Protein Engineering Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Protein Engineering Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End User
  • 7.3.3. Spain Protein Engineering Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Protein Engineering Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End User
  • 7.3.5. United Kingdom Protein Engineering Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End User

8. North America Protein Engineering Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Protein Engineering Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End User
  • 8.3.2. Mexico Protein Engineering Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End User
  • 8.3.3. Canada Protein Engineering Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End User

9. South America Protein Engineering Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Engineering Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Protein Engineering Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Protein Engineering Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End User

10. Middle East and Africa Protein Engineering Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Technology
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Engineering Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Protein Engineering Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Protein Engineering Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Protein Engineering Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Agilent Technologies Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Amgen Inc.
• 16.3. Bruker Corporation
• 16.4. Bio-Rad Laboratories Inc.
• 16.5. Eli Lilly and Company
• 16.6. Merck KGaA
• 16.7. Novo Nordisk AS
• 16.8. PerkinElmer Inc.
• 16.9. Thermo Fisher Scientific Inc.
• 16.10.Waters Corporation

17. Strategic Recommendations

18. About Us & Disclaimer